A skeleton model for the network of cyclin-dependent kinases driving the mammalian cell cycle

被引:59
作者
Gerard, Claude [1 ]
Goldbeter, Albert [1 ]
机构
[1] Univ Libre Bruxelles ULB, Fac Sci, B-1050 Brussels, Belgium
关键词
oscillations; cell cycle; model; systems biology; RESTRICTION POINT; ENDOREPLICATION; OSCILLATIONS; HYSTERESIS; CHAOS; CDC2;
D O I
10.1098/rsfs.2010.0008
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We previously proposed a detailed, 39-variable model for the network of cyclin-dependent kinases (Cdks) that controls progression along the successive phases of the mammalian cell cycle. Here, we propose a skeleton, 5-variable model for the Cdk network that can be seen as the backbone of the more detailed model for the mammalian cell cycle. In the presence of sufficient amounts of growth factor, the skeleton model also passes from a stable steady state to sustained oscillations of the various cyclin/Cdk complexes. This transition corresponds to the switch from quiescence to cell proliferation. Sequential activation of the cyclin/Cdk complexes allows the ordered progression along the G1, S, G2 and M phases of the cell cycle. The 5-variable model can also account for the existence of a restriction point in G1, and for endoreplication. Like the detailed model, it contains multiple oscillatory circuits and can display complex oscillatory behaviour such as quasi-periodic oscillations and chaos. We compare the dynamical properties of the skeleton model with those of the more detailed model for the mammalian cell cycle.
引用
收藏
页码:24 / 35
页数:12
相关论文
共 50 条
  • [41] A Hybrid Model of Mammalian Cell Cycle Regulation
    Singhania, Rajat
    Sramkoski, R. Michael
    Jacobberger, James W.
    Tyson, John J.
    PLOS COMPUTATIONAL BIOLOGY, 2011, 7 (02)
  • [42] Control of cell division and transcription by cyclin-dependent kinase-activating kinases in plants
    Umeda, M
    Shimotohno, A
    Yamaguchi, M
    PLANT AND CELL PHYSIOLOGY, 2005, 46 (09) : 1437 - 1442
  • [43] Regulators of G1 cyclin-dependent kinases and cancers
    Lee, MH
    Yang, HY
    CANCER AND METASTASIS REVIEWS, 2003, 22 (04) : 435 - 449
  • [44] Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer
    Rahman, Razia
    Selth, Luke A.
    TRANSLATIONAL ONCOLOGY, 2025, 55
  • [45] Properties and potential applications of chemical inhibitors of cyclin-dependent kinases
    Meijer, L
    Leclerc, S
    Leost, M
    PHARMACOLOGY & THERAPEUTICS, 1999, 82 (2-3) : 279 - 284
  • [46] Cyclin-dependent kinases: bridging their structure and function through computations
    De Vivo, Marco
    Bottegoni, Giovanni
    Berteotti, Anna
    Recanatini, Maurizio
    Luigi Gervasio, Francesco
    Cavalli, Andrea
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (12) : 1551 - 1559
  • [47] Transcriptional cyclin-dependent kinases as the mediators of inflammation-a review
    Sundar, Vaishnavi
    Vimal, Sanjana
    Mithlesh, M. S. Sai
    Dutta, Anupam
    Tamizhselvi, Ramasamy
    Manickam, Venkatraman
    GENE, 2021, 769
  • [48] Small molecule modulators of cyclin-dependent kinases for cancer therapy
    Adrian M Senderowicz
    Oncogene, 2000, 19 : 6600 - 6606
  • [49] Clinical anticancer drug development: targeting the cyclin-dependent kinases
    Benson, C
    Kaye, S
    Workman, P
    Garrett, M
    Walton, M
    de Bono, J
    BRITISH JOURNAL OF CANCER, 2005, 92 (01) : 7 - 12
  • [50] THE CYCLIN-DEPENDENT PROTEIN-KINASES AND THE CONTROL OF CELL-DIVISION .1.
    DOREE, M
    GALAS, S
    FASEB JOURNAL, 1994, 8 (14) : 1114 - 1121